Chagas drug: Kalobios gets FDA okay on development of benznidazole
by News Desk from Outbreak News Today on (#27WSH)
California based biopharmaceutical company, KaloBios Pharmaceuticals, Inc. yesterday announced positive guidance in the minutes from a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the development plans for benznidazole for the treatment of Chagas disease, a neglected tropical disease. Benznidazole is an oral anti-parasitic medication used in the treatment of Chagas ["]
The post Chagas drug: Kalobios gets FDA okay on development of benznidazole appeared first on Outbreak News Today.